BridgeMD
New treatment option for Tourette Syndrome
Official title Internet-based Behavior Therapy for Adults With Tourette Syndrome
ClinicalTrials.gov ID: NCT06271083
What this study is testing
- What it's testing
- This study protocol outlines a parallel-group, randomized controlled trial (RCT) designed to evaluate the effectiveness of Internet-delivered behavior therapy (BT) based on exposure with response prevention (ERP) for adults with Tourette syndrome (TS) or chronic tic disorder (CTD). The primary aim is to evaluate the effects of Internet-delivered ERP-based BT on tic severity compared to a control condition offering general psychological support at week 11 counting from the treatment start.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ≥ 18 years of age.
- Primary diagnosis of TS/CTD, according to criteria in Diagnostic and Statistical Manual of mental disorders 5th edition.
- Provided digital informed consent.
- Have a Total Tic Severity Score (TTS) of \>15, or \>10 for individuals with motor or vocal tics only, in the past week, as measured by the Yale...
- Being willing and able to follow the study procedures and participate in the 10-week treatment program.
You likely can't join if
- Ongoing or planned psychological treatment for TS/CTD.
- Previous BT for tics of a minimum of 8 sessions with a qualified therapist within 12 months prior to assessment.
- Adjustment of medication for tics within the last two months prior to assessment.
- Severe psychiatric comorbidities such as organic brain disorders, bipolar disorder, ongoing psychosis, anorexia nervosa or substance use disorders...
- Acute psychiatric problems such as severe depression or suicidal risk needing immediate psychiatric care.
- Severe tics causing immediate risk to the participants themselves or to others and requiring urgent medical attention.
See the full eligibility criteria
- ≥ 18 years of age.
- Primary diagnosis of TS/CTD, according to criteria in Diagnostic and Statistical Manual of mental disorders 5th edition.
- Provided digital informed consent.
- Have a Total Tic Severity Score (TTS) of \>15, or \>10 for individuals with motor or vocal tics only, in the past week, as measured by the Yale Global Tic Severity Scale (YGTSS).
- Being willing and able to follow the study procedures and participate in the 10-week treatment program.
- Being fluent in Swedish.
- Have regular access to a computer connected to the Internet, sufficient technical skills to use the treatment platform, as well as a mobile phone to receive text messages.
- Ongoing or planned psychological treatment for TS/CTD.
- Previous BT for tics of a minimum of 8 sessions with a qualified therapist within 12 months prior to assessment.
- Adjustment of medication for tics within the last two months prior to assessment.
- Severe psychiatric comorbidities such as organic brain disorders, bipolar disorder, ongoing psychosis, anorexia nervosa or substance use disorders that can interfere with the treatment for TS/CTD.
- Acute psychiatric problems such as severe depression or suicidal risk needing immediate psychiatric care.
- Severe tics causing immediate risk to the participants themselves or to others and requiring urgent medical attention.
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.